leadf
logo-loader

Abimmune Biopharma

Receive alerts
Market:
Unlisted
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Abimmune Biopharma is a startup company that focuses on generating novel nanobody based drug candidates against a wide spectrum of high-value immunomodulatory and oncology targets related to T lymphocytes, solid tumors, and tumor stem cells.